Riskpilot← Back to searchSign inGet full accesshemedic ApS
APSActiveCVR 36708492Byskellet 9Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20153 employees
Revenue 2025
DKK 2,8M
-22% vs 2024
EBITDA margin
52.7%
-39% vs 2024
Equity ratio
49.9%
Financial strength
Net profit 2025
DKK 1,2M
-39% vs 2024
| Revenue | DKK 2,8M | -22% |
| EBITDA | DKK 1,5M | -39% |
| Net profit | DKK 1,2M | -39% |
| Total assets | DKK 4,9M | -21% |
| Equity | DKK 2,4M | -26% |
| Employees | 3 | — |
Legal name
hemedic ApS
CVR number
36708492
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
3. april 2015
Share capital
DKK 50.000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabet formål er, at drive virksomhed med salg af produkter til hospitaler, samt enhver i forbindelse hermed stående virksomhed.
Address
Byskellet 9
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -25 | 212 | 347 | 853 | 653 | 753 | 613 | 727 | 2.176 | 3.637 | 2.821 |
| Staff expenses | -129 | -201 | -229 | -407 | -494 | -527 | -616 | -687 | -1.102 | -1.218 | -1.335 |
| EBITDA | -154 | 11 | 118 | 446 | 159 | 226 | -3 | 40 | 1.074 | 2.420 | 1.486 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -19 | -32 | -32 | -77 | -0 | -0 |
| EBIT | -154 | 11 | 118 | 446 | 159 | 207 | -35 | 8 | 997 | 2.420 | 1.486 |
| Net financials | -2 | -2 | -3 | -3 | -10 | -13 | -29 | -29 | -19 | 26 | 19 |
| Profit before tax | -156 | 9 | 115 | 442 | 149 | 195 | -64 | -21 | 977 | 2.446 | 1.505 |
| Tax | -0 | -0 | -0 | -0 | 41 | 49 | -8 | 1 | 231 | 552 | 348 |
| Net profit | -156 | 9 | 115 | 442 | 108 | 146 | -56 | -22 | 747 | 1.894 | 1.157 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 198 | 330 | 519 | 2.447 | 1.046 | 1.370 | 1.593 | 1.965 | 3.885 | 6.147 | 4.880 |
| Equity | -106 | -97 | 18 | 460 | 568 | 714 | 658 | 636 | 1.383 | 3.277 | 2.433 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.797 | 0 | 0 |
| Short-term debt | 304 | 428 | 501 | 1.987 | 478 | 652 | 935 | 1.329 | 705 | 2.871 | 2.447 |
| Total debt | 304 | 428 | 501 | 1.987 | 478 | 652 | 935 | 1.329 | 2.502 | 2.871 | 2.447 |
EBITDA margin
52.7%
This company
15.8%
Market median
+234% vs market
20152025
Equity ratio
49.9%
This company
38.2%
Market median
+31% vs market
20152025
Return on equity
47.5%
This company
18.4%
Market median
+158% vs market
20152025
Net profit margin
41.0%
This company
8.1%
Market median
+406% vs market
20152025
Asset turnover
0.58×
This company
1.12×
Market median
-48% vs market
20152025
Debt / equity
1.01×
This company
0.62×
Market median
-63% vs market
20152025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-04-03 – 2015-12-31
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2015 | |
KØLA HOLDING ApS | Company | 100.0% | 100.0% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of hemedic ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|